A Therapeutic Strategy for Preferential Targeting of <i>TET2</i>-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms

Yihong Guan, Anand D. Tiwari, James G. Phillips, Metis Hasipek, Dale R. Grabowski, Simona Pagliuca, Priyanka Gopal, Cassandra M. Kerr, Vera Adema, Tomas Radivoyevitch, Yvonne Parker, Daniel J. Lindner, Manja Meggendorfer, Mohamed Abazeed, Mikkeal A. Sekeres, Omar Y. Mian, Torsten Haferlach, Jaroslaw P. Maciejewski, Babal K. Jha

Open source

DOI: 10.1158/2643-3230.bcd-20-0173
Published: 2020-12-07
Container: Blood Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2643-3230.bcd-20-0173,
  title = {A Therapeutic Strategy for Preferential Targeting of <i>TET2</i>-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms},
  author = {Yihong Guan and Anand D. Tiwari and James G. Phillips and Metis Hasipek and Dale R. Grabowski and Simona Pagliuca and Priyanka Gopal and Cassandra M. Kerr and Vera Adema and Tomas Radivoyevitch and Yvonne Parker and Daniel J. Lindner and Manja Meggendorfer and Mohamed Abazeed and Mikkeal A. Sekeres and Omar Y. Mian and Torsten Haferlach and Jaroslaw P. Maciejewski and Babal K. Jha},
  year = {2020},
  journal = {Blood Cancer Discovery},
  doi = {10.1158/2643-3230.bcd-20-0173},
  url = {https://doi.org/10.1158/2643-3230.bcd-20-0173}
}

RIS

TY  - JOUR
TI  - A Therapeutic Strategy for Preferential Targeting of <i>TET2</i>-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms
AU  - Yihong Guan
AU  - Anand D. Tiwari
AU  - James G. Phillips
AU  - Metis Hasipek
AU  - Dale R. Grabowski
AU  - Simona Pagliuca
AU  - Priyanka Gopal
AU  - Cassandra M. Kerr
AU  - Vera Adema
AU  - Tomas Radivoyevitch
AU  - Yvonne Parker
AU  - Daniel J. Lindner
AU  - Manja Meggendorfer
AU  - Mohamed Abazeed
AU  - Mikkeal A. Sekeres
AU  - Omar Y. Mian
AU  - Torsten Haferlach
AU  - Jaroslaw P. Maciejewski
AU  - Babal K. Jha
PY  - 2020
JO  - Blood Cancer Discovery
DO  - 10.1158/2643-3230.bcd-20-0173
UR  - https://doi.org/10.1158/2643-3230.bcd-20-0173
ER  -

APA

Guan, Y., Tiwari, A. D., Phillips, J. G., Hasipek, M., Grabowski, D. R., Pagliuca, S., Gopal, P., Kerr, C. M., Adema, V., Radivoyevitch, T., Parker, Y., Lindner, D. J., Meggendorfer, M., Abazeed, M., Sekeres, M. A., Mian, O. Y., Haferlach, T., Maciejewski, J. P., & Jha, B. K. (2020). A Therapeutic Strategy for Preferential Targeting of <i>TET2</i>-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms. Blood Cancer Discovery. https://doi.org/10.1158/2643-3230.bcd-20-0173

Source records

crossref · retrieved 2026-09-26T04:04:50.182Z